Phase 3 clinical trial of COVID-19 inactivated vaccine kicks off in Abu Dhabi

The world’s first WHO-listed Phase 3 clinical trial of the COVID-19 inactivated vaccine has begun in Abu Dhabi, with Department of Health-Abu Dhabi Chairman Sheikh Abdullah bin Mohammed Al Hamed being the first to participate in the trial, followed by Acting Undersecretary Dr. Jamal Al Kaabi.

Abu Dhabi-based G42 Healthcare is performing trials in cooperation with Sinopharm CNBG, under the administration of DoH and the Ministry of Health.

The partnership will help provide quick access to the vaccine for UAE residents, with manufacturing taking place in Abu Dhabi.